JW Holdings

096760 · KOSPI · ₩096760 · JW홀딩스

₩3,825▼ ₩75 (1.92%)End-of-day · Oct 26, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y +13.67%
Market cap
₩283B
Enterprise value
₩331B
P/E
3.3×
P/B
1.0×
Dividend yield
5.6%
ROE
29.1%
Net margin
8.4%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−19.0% from the high

₩3,195Today: ₩3,825 – ₩4,045₩4,720

Returns

  • 1W−5.6%
  • 1M−11.6%
  • 3M−0.6%
  • 6M−12.9%
  • YTD+6.5%
  • 1Y+17.5%
Volume today
37,390
0.6× the 20-day average
Traded today
₩144M
Listed shares
73,924,942
EPS (12 months)
₩1,143
Earnings yield 29.9%

Signals

36Quiet
  • BuzzQuietBuzz 36 of 100 (50 is a normal day for this stock).
  • MomentumWeak-12.3% over the last month; the price is below its 20-day average.

Signals describe activity, not recommendations. Not financial advice.

JW Holdings stock overview

JW Holdings (JW홀딩스, KRX: 096760) is listed on KOSPI, in the Holding companies sector. JW Holdings Corporation is a Korean business holding company established in 2007 through a spin-off from JW Pharmaceutical, and listed on the Korea Exchange later that year. Its shares closed at ₩3,825 on Oct 26, 2026, down 1.92% on the day, giving it a market value of ₩283B.

Key facts

Market cap
₩283B
Sector
Holding companies
Latest price change
−1.92%
As of
Oct 26, 2026
Main business
JW Holdings Corporation is a Korean business holding company established in 2007 through a spin-off from JW Pharmaceutical, and listed on the Korea Exchange later that year.

Quick answers about JW Holdings

What does JW Holdings do?
JW Holdings Corporation is a Korean business holding company established in 2007 through a spin-off from JW Pharmaceutical, and listed on the Korea Exchange later that year. Besides holding stakes in its subsidiaries, it directly handles overseas business for its subsidiaries and grandchild companies, which produce raw materials, finished pharmaceuticals, and medical devices, and earns income from dividends, brand royalties, and management services. Its main products include parenteral nutrition and fluid solutions, penem antibiotics, and itraconazole, and its subsidiaries supply pharmaceutical products to hospitals and other customers.
What is the market cap of JW Holdings?
The market capitalisation of JW Holdings was ₩283B at the close on Oct 26, 2026.
Who are the largest shareholders of JW Holdings?
According to the latest official filings, the largest reported holders are Lee Kyung-ha (52.56%, as of Oct 7, 2026); National Pension Service (0.49%, as of Dec 31, 2025); EMERGING MARKETS CORE EQUITY 2 PORTFOLIO (0.28%, as of Jul 31, 2026).
When is the next earnings report from JW Holdings?
Korean companies rarely announce results dates in advance. Based on when JW Holdings filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Does the National Pension Service own JW Holdings?
Yes. The National Pension Service held 0.49% of JW Holdings shares as of Dec 31, 2025.

Company profile

JW Holdings Corporation is a Korean business holding company established in 2007 through a spin-off from JW Pharmaceutical, and listed on the Korea Exchange later that year. Besides holding stakes in its subsidiaries, it directly handles overseas business for its subsidiaries and grandchild companies, which produce raw materials, finished pharmaceuticals, and medical devices, and earns income from dividends, brand royalties, and management services. Its main products include parenteral nutrition and fluid solutions, penem antibiotics, and itraconazole, and its subsidiaries supply pharmaceutical products to hospitals and other customers.

Written by AI from the company's latest annual report.

Korean name
JW홀딩스
CEO
이경하, 차성남
Founded
Jul 2007
Listed
Jul 2007
Listed shares
73,924,942
Fiscal year ends
Month 12

Similar companies

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: JW Holdings / JW홀딩스 / 096760 / KRX:096760

Source: KRX statistical information